Cargando…

Nanoparticles as an effective drug delivery system in COVID-19

BACKGROUND: The global healthcare sector has been dealing with a situation known as a novel severe acute respiratory syndrome (SARS-CoV-2) since the end of 2019. Covid-19 is an acronym for Covid-19 (Coronavirus Disease- 2019). It causes a respiratory infection that includes cold, sneezing and coughi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Neehasri Kumar, Deepika, Choudhury, Reshma, Sonawane, Gaurav Ambadas, Mavinamar, Shankar, Lyu, Xiaoming, Pandey, Ramendra Pati, Chang, Chung-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426213/
https://www.ncbi.nlm.nih.gov/pubmed/34649334
http://dx.doi.org/10.1016/j.biopha.2021.112162
_version_ 1783749994883317760
author Chowdhury, Neehasri Kumar
Deepika
Choudhury, Reshma
Sonawane, Gaurav Ambadas
Mavinamar, Shankar
Lyu, Xiaoming
Pandey, Ramendra Pati
Chang, Chung-Ming
author_facet Chowdhury, Neehasri Kumar
Deepika
Choudhury, Reshma
Sonawane, Gaurav Ambadas
Mavinamar, Shankar
Lyu, Xiaoming
Pandey, Ramendra Pati
Chang, Chung-Ming
author_sort Chowdhury, Neehasri Kumar
collection PubMed
description BACKGROUND: The global healthcare sector has been dealing with a situation known as a novel severe acute respiratory syndrome (SARS-CoV-2) since the end of 2019. Covid-19 is an acronym for Covid-19 (Coronavirus Disease- 2019). It causes a respiratory infection that includes cold, sneezing and coughing, and pneumonia. In the case of an animal, it causes diarrhea and upper respiratory diseases. Covid-19 transmitted human to human via airborne droplets. First Covid-19 emerged in Wuhan market China and it spread rapidly throughout the World. As we know nanoparticles are a novel drug delivery system. They have various advantageous effects like increasing the efficacy of the drug, safety, etc. In this review, we study about the nanoparticles and summarize how it is effective during drug delivery system in Covid-19. Chitosan is a much focused biopolymeric nanoparticle. It delivers drugs to the specific target site. In a recent health crisis, chitosan nanoparticles are one of the ways to release drugs of Covid-19, and specifically in the lungs of the affected patients. We studied and extracted our data from various research papers, review papers, and some other articles. OBJECTIVE: The main goal is to study the nanoparticles and their future aspects which is an effective drug delivery system in Covid-19. METHODS: The bibliographic search was done through a systematic search. The terms “Nanoparticles”, “Covid-19 ”, “Drug delivery” etc. were used to search the databases/search engines like “Google Scholar”, “NCBI”, “PubMed”, “Science Direct” etc. These databases and search engines used here perform the limited criteria of search to conduct a systematic literature survey for the study and report writing. All the text from the articles and research papers were studied and analyzed. The various articles and research papers were used in writing this report and all of which are mentioned in the reference section of this report. CONCLUSION: Our current studies reveal that nanoparticles may prove very helpful in the delivery of drugs for Covid-19 treatment. Many cases showed that patients, where drugs are delivered with the help of nanoparticles, produced very few side effects.
format Online
Article
Text
id pubmed-8426213
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-84262132021-09-09 Nanoparticles as an effective drug delivery system in COVID-19 Chowdhury, Neehasri Kumar Deepika Choudhury, Reshma Sonawane, Gaurav Ambadas Mavinamar, Shankar Lyu, Xiaoming Pandey, Ramendra Pati Chang, Chung-Ming Biomed Pharmacother Article BACKGROUND: The global healthcare sector has been dealing with a situation known as a novel severe acute respiratory syndrome (SARS-CoV-2) since the end of 2019. Covid-19 is an acronym for Covid-19 (Coronavirus Disease- 2019). It causes a respiratory infection that includes cold, sneezing and coughing, and pneumonia. In the case of an animal, it causes diarrhea and upper respiratory diseases. Covid-19 transmitted human to human via airborne droplets. First Covid-19 emerged in Wuhan market China and it spread rapidly throughout the World. As we know nanoparticles are a novel drug delivery system. They have various advantageous effects like increasing the efficacy of the drug, safety, etc. In this review, we study about the nanoparticles and summarize how it is effective during drug delivery system in Covid-19. Chitosan is a much focused biopolymeric nanoparticle. It delivers drugs to the specific target site. In a recent health crisis, chitosan nanoparticles are one of the ways to release drugs of Covid-19, and specifically in the lungs of the affected patients. We studied and extracted our data from various research papers, review papers, and some other articles. OBJECTIVE: The main goal is to study the nanoparticles and their future aspects which is an effective drug delivery system in Covid-19. METHODS: The bibliographic search was done through a systematic search. The terms “Nanoparticles”, “Covid-19 ”, “Drug delivery” etc. were used to search the databases/search engines like “Google Scholar”, “NCBI”, “PubMed”, “Science Direct” etc. These databases and search engines used here perform the limited criteria of search to conduct a systematic literature survey for the study and report writing. All the text from the articles and research papers were studied and analyzed. The various articles and research papers were used in writing this report and all of which are mentioned in the reference section of this report. CONCLUSION: Our current studies reveal that nanoparticles may prove very helpful in the delivery of drugs for Covid-19 treatment. Many cases showed that patients, where drugs are delivered with the help of nanoparticles, produced very few side effects. The Authors. Published by Elsevier Masson SAS. 2021-11 2021-09-09 /pmc/articles/PMC8426213/ /pubmed/34649334 http://dx.doi.org/10.1016/j.biopha.2021.112162 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Chowdhury, Neehasri Kumar
Deepika
Choudhury, Reshma
Sonawane, Gaurav Ambadas
Mavinamar, Shankar
Lyu, Xiaoming
Pandey, Ramendra Pati
Chang, Chung-Ming
Nanoparticles as an effective drug delivery system in COVID-19
title Nanoparticles as an effective drug delivery system in COVID-19
title_full Nanoparticles as an effective drug delivery system in COVID-19
title_fullStr Nanoparticles as an effective drug delivery system in COVID-19
title_full_unstemmed Nanoparticles as an effective drug delivery system in COVID-19
title_short Nanoparticles as an effective drug delivery system in COVID-19
title_sort nanoparticles as an effective drug delivery system in covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426213/
https://www.ncbi.nlm.nih.gov/pubmed/34649334
http://dx.doi.org/10.1016/j.biopha.2021.112162
work_keys_str_mv AT chowdhuryneehasrikumar nanoparticlesasaneffectivedrugdeliverysystemincovid19
AT deepika nanoparticlesasaneffectivedrugdeliverysystemincovid19
AT choudhuryreshma nanoparticlesasaneffectivedrugdeliverysystemincovid19
AT sonawanegauravambadas nanoparticlesasaneffectivedrugdeliverysystemincovid19
AT mavinamarshankar nanoparticlesasaneffectivedrugdeliverysystemincovid19
AT lyuxiaoming nanoparticlesasaneffectivedrugdeliverysystemincovid19
AT pandeyramendrapati nanoparticlesasaneffectivedrugdeliverysystemincovid19
AT changchungming nanoparticlesasaneffectivedrugdeliverysystemincovid19